Evidence map›Paper›PMID 30595854›Full record

ArticleCurrent health sciences journal

Immunohistochemical Study of Sentinel Lymph Node in Colon Cancer.

M C Sfeclan, C S Mirea, M C Ciorbagiu, A M Vîlcea, C V Obleagă, V Pădureanu, D Cârţu, T Ș Țenea-Cojan, E Moraru, I D Vîlcea

Abstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

M C SfeclanThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
C S MireaThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
M C CiorbagiuThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
A M VîlceaDepartment of Dermatology-Venerology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
C V ObleagăThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
V PădureanuThe 2nd Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
D CârţuThe 1st Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
T Ș Țenea-CojanThe 4th Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
E MoraruThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
I D VîlceaThe 2nd Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Romania.
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of sentinel lymph node (SLN) in colon cancer is very important in order to increase the accuracy of lymph node staging. The number of examined lymph nodes represents a significant predictor of survival. This study aims to show the importance of SLN histological and immunohistochemical examination in adjuvant oncological treatment. The study includes 23 patients with colon cancer (44% women and 56% men) who came in our clinic for surgical intervention. In all cases, the SLN was identified and prepared for histological examination. In 13 of the cases, micrometastases were found onhaematoxylin-eosin (HE) staining, there were 5 cases with positive immunohistochemistry using antibodies anti-p53, anti-VEGF-C, anti-CD34, and 5 cases with SLN negative both for HE and immunohistochemistry. Altogether we had a detection rate of 92%, an accuracy of 78,2%, a sensitivity of 90%, a false negative rate of 10% and a negative predictive value of 71,4%, good values according to the literature. Four (17,3%) patients had micrometastases exclusively in the sentinel lymph node, after performing additional histological examination, using multilevel section and immunohistochemistry. After assessing the SNL on our patients, we concluded that it is a reproducible practice for lymph node analysis.

Indexed as

colon cancerImmunohistochemistrysentinel lymph node

Identifiers

PMID30595854
PMCPMC6286729
OpenAlexW3021984431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.